Aug 31, 2026
BioMarin (BMRN) Stock Secures Victory in Patent Dispute, Gains Royalty Stream Through 2030
BioMarin (BMRN) stock adds royalty revenue after patent settlement with Ascendis Pharma over CNP technology, securing payments through May 2030.
The post BioMarin (BMRN) Stock Secures Victory in Patent Dispute, Gains Royalty Stream Through 2030 appeared first on Blockonomi.
Source: Blockonomi →Related News
- 38 minutes ago
ARK Invest Pours $38M Into Meta (META) While Offloading CrowdStrike (CRWD) Stock
- 43 minutes ago
X Adds Crypto and Stock Trading Links to Cashtags for US Users
- 45 minutes ago
Microsoft (MSFT) Stock Rises on Azure Pricing Strategy and Mid-40% Growth Moment...
- 57 minutes ago
AMD (AMD) Stock Achieves $1 Trillion Valuation After Nearly Tripling in 2026
- 58 minutes ago
Intel (INTC) Stock Explodes 12% Higher: What’s Driving the Chip Rally?